Share this @internewscast.com

Expert joins CBS New York to discuss new sickle cell treatment


Expert joins CBS New York to discuss new sickle cell treatment

02:46

Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.

In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel Prize in 2020.

Casgevy — made by the Boston-based Vertex Pharmaceuticals (Europe) Ltd. and CRISPR Therapeutics — was approved by the agency for the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. 

To date, bone marrow transplants, extremely arduous procedures that come with very unpleasant side effects, have been the only long-lasting treatment.

“The future of life-changing cures resides in CRISPR based (gene-editing) technology,” said Dr. Helen O’Neill of University College London.

“The use of the word ‘cure’ in relation to sickle cell disease or thalassemia has, up until now, been incompatible,” she said in a statement, calling the MHRA’s approval of gene therapy “a positive moment in history.”

Both sickle cell disease and thalassemia are caused by mistakes in the genes that carry hemoglobin, the protein in red blood cells that carry oxygen.

In people with sickle cell — which is particularly common in people with African or Caribbean heritage — a genetic mutation causes the cells to become crescent-shaped, which can block blood flow and cause excruciating pain, organ damage, stroke and other problems.

In people with thalassemia, the genetic mutation can cause severe anemia. Patients typically require blood transfusions every few weeks, and injections and medicines for their entire life. Thalassemia predominantly affects people of South Asian, Southeast Asian and Middle Eastern heritage.

The new medicine, Casgevy, works by targeting the problematic gene in a patient’s bone marrow stem cells so that the body can make properly functioning hemoglobin.

Patients first receive a course of chemotherapy, before doctors take stem cells from the patient’s bone marrow and use genetic editing techniques in a laboratory to fix the gene. The cells are then infused back into the patient for a permanent treatment. Patients must be hospitalized at least twice — once for the collection of the stem cells and then to receive the altered cells.

Britain’s regulator said its decision to authorize the gene therapy for sickle cell disease was based on a study done on 29 patients, of whom 28 reported having no severe pain problems for at least one year after being treated. In the study for thalassemia, 39 out of 42 patients who got the therapy did not need a red blood cell transfusion for at least a year afterwards.

Gene therapy treatments can cost millions of dollars and experts have previously raised concerns that they could remain out of reach for the people who would benefit most.

Last year, Britain approved a gene therapy for a fatal genetic disorder that had a list price of £2.8 million ($3.5 million). England’s National Health Service negotiated a significant confidential discount to make it available to eligible patients.

Vertex Pharmaceuticals said it had not yet established a price for the treatment in Britain and was working with health authorities “to secure reimbursement and access for eligible patients as quickly as possible.”

In the U.S., Vertex has not released a potential price for the therapy, but a report by the nonprofit Institute for Clinical and Economic Review said prices up to around $2 million would be cost-effective. By comparison, research earlier this year showed medical expenses for current sickle cell treatments, from birth to age 65, add up to about $1.6 million for women and $1.7 million for men.

Medicines and treatments in Britain must be recommended by a government watchdog before they are made freely available to patients in the national health care system.

Casgevy is currently being reviewed by the U.S. Food and Drug Administration; the agency is expected to make a decision early next month, before considering another sickle cell gene therapy.

Millions of people around the world, including about 100,000 in the U.S., have sickle cell disease. It occurs more often among people from places where malaria is or was common, like Africa and India, and is also more common in certain ethnic groups, such as people of African, Middle Eastern and Indian descent. Scientists believe being a carrier of the sickle cell trait helps protect against severe malaria.

Dr. Jon LaPook has reported on another effort to harness gene therapy to cure sickle cell disease. Watch that story in the video below:


Could gene therapy cure sickle cell anemia?

13:35

Share this @internewscast.com
You May Also Like

Understanding Charcot-Marie-Tooth: The Rare Disease Behind the Tragic Loss of 9-1-1 Nashville’s Isabelle Tate

The young actress from 9-1-1 Nashville, who passed away at the age…

Grandmother’s Dramatic 5-Stone Weight Loss with Mounjaro Exposes Unexpected ‘Melted Welly’ Effect

A grandmother from Cumbernauld, Lanarkshire, who shed five stone with the help…

Boost Your Alertness with a Simple 5p Sweet: Study Reveals Surprising Benefits as Clocks Roll Back

The study uncovered the benefits of the herb, which may come in…

Why Cholera Still Persists: Insights from Hakainde Hichilema and Tedros Adhanom Ghebreyesus

The United Kingdom last experienced a cholera outbreak in 1866, while the…

Skipping This Daily Ritual Could Skyrocket Your Stroke Risk – It’s Not Exercise!

Adopting a healthier lifestyle by incorporating regular exercise, quitting smoking, and maintaining…

After Spending £1,700 on Ozempic, I Gained Weight – Here’s What You Need to Know

A woman has shared her experience of spending over £1,700 on a…

Evolution of the Ideal Female Body: A Century of Changing Beauty Standards

In a world where beauty ideals are constantly evolving, many women find…

Insights from Boris Johnson: Lessons on Living with Cancer and the Learning Curve Ahead

Ed Miliband, caught mid-bite on a bacon sandwich, looked like someone waking…

Subtle Indicators of a Brain Aneurysm: Insights Following Kim Kardashian’s Recent Diagnosis

Kim Kardashian recently alarmed her followers by disclosing her diagnosis of a…

Discover the 15-Minute Pharmacist-Approved Method to Relieve Heartburn Permanently

Dealing with heartburn can be challenging, but a simple routine might just…

Breaking Free After 20 Years: The Bold Tinnitus Treatment Doctors Won’t Tell You About

Ayahuasca, a potent hallucinogenic brew, has become a popular remedy among wellness…

Former ‘Biggest Loser’ Contestants Share Secrets to Long-Term Weight Loss Success Without Ozempic

Half a decade after the curtain fell on The Biggest Loser’s final…